News

This article will explore the issues of a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.

Outlining the techniques for anonymization of clinical study reports and the identification and redaction of commercially confidential information to comply with EMA's Policy 0070 on trial data disclosure and transparency.

Metabolomics can make a positive impact from early drug discovery through clinical development and beyond.

Updated employee announcements, business news, awards, and recognition in the industry today.

The Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.

Investigators aim to increase the efficiency and consistency of FDA’s Bioresearch Monitoring program.

In this article, we will suggest an introspective method that can help clarify situational analysis and resolution.

The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.